You are here

Bacteriophage-based Control of American Foulbrood in Honeybees

Award Information
Agency: Department of Health and Human Services
Branch: Food and Drug Administration
Contract: 1R43FD003867-01
Agency Tracking Number: FD003867
Amount: $90,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: FDA
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2010
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
535 W Research Blvd., Suite 135, M/S 300
FAYETTEVILLE, AR 72701
United States
DUNS: 125476825
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 LISA BIELKE
 (479) 571-2592
 LISA.BIELKE@BIODETECTION-INSTRUMENTS.COM
Business Contact
 MARK KIDD
Phone: (479) 571-2592
Email: mwagstaff@virtual-incubation.com
Research Institution
N/A
Abstract

NIH Project Summary:  This Small Business Innovation Research Phase I project will demonstrate feasibility for  development of a bacteriophage-based preventative and treatment for American Foulbrood in  honey bees. Phase I will focus on development of a bacteriophage treatment for P. larvae as a  therapy for American Fouldbrood. In addition, efforts will be made to minimize the impact of the  bacteriophage treatment on the commensal bacteria in the gastrointestinal tract of the honey  bees. Phase II in vivo studies will be conducted at the experimental apiaries at the University  of Arkansas. BioDetection Instruments will also work closely with the appropriate agencies to  make certain that all regulatory requirements are met before the final product(s) is marketed.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government